Literature DB >> 4654779

[Pharmacologic analysis of a new case of postanoxic intention and action myoclonus].

F Lhermitte, R Marteau, C F Degos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4654779

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


× No keyword cloud information.
  9 in total

1.  Letter: Methysergide ineffective in spasticity.

Authors:  G M Yuill
Journal:  Br Med J       Date:  1976-07-03

2.  Segmental action and stimuli-sensitive myoclonus with acute onset. A case report.

Authors:  G Avanzini; S Franceschetti; B Lombardi; A Passerini
Journal:  Ital J Neurol Sci       Date:  1980-10

3.  Post-hypoxic action (intention) myoclonus: a clinico-electroencephalographic study.

Authors:  O W Witte; E Niedermeyer; G Arendt; H J Freund
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

4.  Postanoxic myoclonus. Treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor.

Authors:  E Beretta; F Regli; G de Crousaz; A J Steck
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

5.  Regional central serotonin receptor binding in rats treated chronically with high-dose 5-hydroxy-L-tryptophan.

Authors:  M R Pranzatelli
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

6.  Observations on chloralose-induced myoclonus in guinea-pigs.

Authors:  D Chadwick; M Hallett; P Jenner; C D Marsden
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

7.  Post-anoxic action myoclonus (Lance-Adams syndrome) treated with levodopa and GABAergic drugs.

Authors:  A Coletti; A Mandelli; G Minoli; G Tredici
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

8.  Dopamine agonists suppress visual-cortical reflex myoclonus.

Authors:  J A Obeso; J Artieda; T Tuñón; M R Luquin; J M Martínez Lage
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

9.  5-Hydroxytryptophan: A method for monitoring human plasma content during clinical administration.

Authors:  P Angwin; P Berger; V Zarcone; H K Brodie; J Barchas
Journal:  Neurochem Res       Date:  1976-12       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.